FDA
-
-
-
-
-
-
-
Chris Bunka, CEO of Lexaria Bioscience Corp., Returns to Uptick Newswire's "Stock Day" Podcast with Everett Jolly to Discuss New Products and Company Evolution
-
-
-
-
-
-
-
Lexaria Bioscience Announces Upcoming Investment Event and Warrant Exercise
-
-
-
-
-
-
-
University of British Columbia to Perform Clinical Study on the Cardiovascular and Cognitive Health Effects of Lexaria's TurboCBD(TM)
-
-
-
-
-
-
-
Lexaria's Ambarii Corporation Announces LOI With Naturally Splendid to Distribute CBD Melts in Japan and South Korea
-
-
-
-
-
-
-
Lexaria Introduces TurboCBD(TM) Brand of High Absorption Full Spectrum Hemp Oil Capsules
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

